PortViewPortView
FMED logo

Fidelity Disruptive Medicine (FMED) ETF Holdings & Analysis

ETFOther

$31.74+0.58%
1-year price historyRange $23.55 – $32.89
52-week range$31.74
$23.48$32.89

What FMED does

This exchange-traded fund allocates capital to pioneering enterprises reshaping medical detection, treatments, and care delivery, encompassing areas from genetic manipulation to automated surgical procedures and online health ecosystems.

Fund profile

Category
Other
AUM
$72.57M
Holdings
10
52-week high
$32.89
52-week low
$23.48

Top holdings

Top 1034%
HoldingWeight
10X GENOMICS INC4.75%
NET OTHER ASSETS4.06%
SECURITIES LENDING CF4.04%
THERMO FISHER SCIENTIFIC INC3.51%
DANAHER CORP3.41%
NATERA INC3.20%
ARGENX SE SPONSORED ADR2.93%
LIFESTANCE HEALTH GROUP INC2.74%
REVOLUTION MEDICINES INC2.63%
ILLUMINA INC2.58%

Sector allocation

Cash & Others1.58%
Healthcare96.82%
Technology1.60%

Geographic allocation

United States84.57%
Other1.12%
Netherlands4.03%
France2.56%
Denmark1.97%
United Kingdom1.83%
Belgium1.60%
Canada1.08%
China0.75%
Switzerland0.48%

PortView Portfolio Insights

PortView analyzes how FMED fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze FMED in PortView →

Related securities

Related stocks

Frequently asked questions

What does FMED track?
FMED is the Fidelity Disruptive Medicine ETF, a Other ETF.
What is the expense ratio of FMED?
Expense ratio data for FMED is shown on the page when available from our data provider.
What are the largest holdings in FMED?
Top holdings include TXG, NET OTHER ASSETS, SECURITIES LENDING CF, TMO, DHR.
How can PortView analyze FMED overlap with other ETFs?
PortView computes the holdings overlap between FMED and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.